(Reuters) - The Medicines and Healthcare products Regulatory Agency has recalled five prescription-only drugs made by India’s Wockhardt Ltd after it found deficiencies in manufacturing procedures at the drugmaker’s Chikalthana factory.
The agency said there was no evidence that the products are defective and that patients who already have the medicines do not need to return them. However, pharmacies dispensing clinics and wholesalers have been asked to stop selling them.
MHRA said its action follows a precautionary recall made by Wockhardt, which is asking retail outlets to return five over-the-counter medicines.
Reporting by Aradhana Aravindan in MUMBAI; Editing by Sunil Nair